Bagos et al. performed a meta-analysis regarding the association of the risk of MS and the CTLA-4 gene polymorphisms and in particular exploring the exon 1 +49 A/G and the promoter -318 C/T polymorphisms [147]. This evidence concerns the gene CTLA4 and myeloid sarcoma.